Phase Ia Clinical Trial of Protein Based Pneumococcal Vaccine
Conditions: Pneumonia; Respiratory Tract Diseases; Respiratory Tract Infections Interventions: Biological: Protein based pneumococcal vaccine(Low dose); Biological: Protein based pneumococcal vaccine placebo(Low dose); Biological: Protein based pneumococcal vaccine(Middle dose); Biological: Protein based pneumococcal vaccine placebo(Middle dose); Biological: Protein based pneu mococcal vaccine(High dose); Biological: Protein based pneumococcal vaccine placebo(High dose) Sponsors: CanSino Biologics Inc.; Henan Center for Disease Control and Prevention Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Research | Vaccines